(R)-5-(1,3-Bis((benzyloxy)carbonyl)guanidino)-2-((tert-butoxycarbonyl)amino)pentanoic acid

Catalog No. :
ACMFGT324
CAS No. :
145881-13-6
Molecular Formula :
C27H34N4O8
Molecular Weight :
542.59

IUPAC Name:Nd,Nw-bis((benzyloxy)carbonyl)-N2-(tert-butoxycarbonyl)-D-arginine

(R)-5-(1,3-Bis((benzyloxy)carbonyl)guanidino)-2-((tert-butoxycarbonyl)amino)pentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$147.00Login to see priceInquiryInquiry
1g95%$264.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-5-(1,3-Bis((benzyloxy)carbonyl)guanidino)-2-((tert-butoxycarbonyl)amino)pentanoic acid
IUPAC NameNd,Nw-bis((benzyloxy)carbonyl)-N2-(tert-butoxycarbonyl)-D-arginine
Molecular FormulaC27H34N4O8
Molecular Weight542.59
SMILESCC(C)(C)OC(=O)N[C@H](CCCN(C(=N)NC(=O)OCC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1)C(=O)O
InChI KeyFVWNVCDDYWITMG-OAQYLSRUSA-N
SynonymN-alpha-Boc-Nomega,omega''-bis-Z-D-arginine;N-ALPHA-T-BUTOXYCARBONYL-N-OMEGA1,N-OMEGA2-BIS-CARBOBENZOXY-D-ARGININE;N-ALPHA-T-BUTOXYCARBONYL-N-OMEGA1,N-OMEGA2-DI-CARBOBENZOXY-D-ARGININE;Boc-D-Arg(Z)-OH;BOC-D-DIBENZYLOXYCARBONYL ARGININE;BOC-D-ARG(Z)2-OH;BOC-D-ARGININE(Z)2-OH;BOC-N-OMEGA,N-OMEGA'-BIS-Z-D-ARGININE
CAS No.145881-13-6

Synthetic Route by SureRoute

1. ACMFGT324 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMFGT324 route product structure diagram
    ACMFGT324145881-13-6
Inquiry

2. ACMFGT324 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMFGT324 route product structure diagram
    ACMFGT324145881-13-6
Inquiry

Comments (0)